Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects

Clinical trial NCT02252809 · COMPLETED

Trial details

NCT number: NCT02252809
Sponsor: Brugmann University Hospital
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Innate Immunity

Start date: 2008-11-01
Primary completion: 2009-04-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.